RAF1 and prostatitis: Our data provide direct evidence implicating that ARF1-mediated Raf1/MEK/ERK1/2 signaling is critical for prostate tumorigenesis and that genetic approaches targeting ARF1 in animal models may provide an important and novel avenue for studying tumorigenesis and developing therapeutics.